Spravato, Nasenspray, Lösung

7680671030013 CH-67103 Nasenspray
Spravato, Nasenspray, Lösung
Spravato, Nasenspray, Lösung
1 / 2
google

Article details

Package size
1
Selling units
unbekannt
Measure
Nasenspray, Lösung à 28 mg (2 Sprühstösse)
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/08/2025
Summary of Product Characteristics
Français
07/08/2025
Summary of Product Characteristics
Italien
07/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
28.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 201.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2022

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
67103
Drug name
Spravato, Nasenspray, Lösung
Galenic form
NASS
ATC Code
N06AX27
Authorization status
Z
Dispensing category
A
First authorization
25/02/2020
Authorization expiration date
31/12/9999
IT Number
01.06.0.
Domain
Human medicine
Field of application
Antidepressivum

Package details

Description (FR)
SPRAVATO spray nasal 28 mg fl
Description (DE)
SPRAVATO Nasenspray 28 mg Fl
Market launch
25/02/2020
Narcotic (BTM)
No

Other package sizes (2)

SPRAVATO spray nasal 28 mg fl 2 pce
2 LEER
GTIN: 7680671030020
View
SPRAVATO spray nasal 28 mg fl 3 pce
3 LEER
GTIN: 7680671030037
View